Skip to main content

ONO PHARMACEUTICAL CO., LTD.

  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • About
      About
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies / Guidelines
    • Company Profile
    • Management
    • Business Locations
    • ONO Story
    • R&D
    • Manufacturing
    • Marketing
    • Safety and Quality Assurance
    • ONO’s 300-Year History
    CLOSE
    Ono Story
    Ono Story
    Videos and Advertisements
    Videos and Advertisements
  • R&D
      R&D
    • Our Mission in R&D / Drug Discovery Approach
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Organization
    • Development Pipeline
    CLOSE
    Development Pipeline
    Development Pipeline
  • Global Business
  • Sustainability
      Sustainability
    • Top message
    • ONO's Approach to CSR
    • Governance
    • Society
    • Environment
    • Social Contribution Activities
    • Policies
    • GRI Content Index
    • CSR Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
    • Corporate Governance
    • Compliance
    • Risk Management
    • Responsible Promotion Activities
    • Innovative Pharmaceutical Products
    • Efforts Made for Improving Access to Healthcare
    • Human Resources and Human Rights
    • Cultivation of Employee-friendly Workplaces/Safety and Health
    • Proper Procurement Activities
    • Global Environment Policy/Environment Challenging Ono Vision(ECO VISION 2050)
    • Environmental Management
    • Environmental Efficiency / Environmental Accounting
    • Approach to social contribution activities
    • Ono’s global policy for social contribution activities
    • Various efforts
    CLOSE
    ECO VISION 2050
    ECO VISION 2050
    ONO SWITCH Project
    ONO SWITCH Project
icon_search_white icon_close_w
  • About
    • About Top
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • History
    • Main Products
    • Videos and Advertisements
    • Policies / Guidelines
    Business Activities
    • R&D
    • Manufacturing
    • Marketing
    • Safety and Quality Assurance
  • R&D
    • R&D Top
    • Our Mission in R&D / Drug Discovery Approach
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Organization
    • Development Pipeline
  • Global Business
    • Global Business Top
  • Sustainability
    • Sustainability Top
    • Top message
    • ONO's Approach to CSR
    • Governance
    • Society
    • Environment
    • Social Contribution Activities
    • Policies
    • GRI Content Index
    • CSR Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
icon_search_g
Home News

News

  • Press Releases
  • Notices

76

  • 2020.
  • 2019.
  • 2018.
  • 2017.
  • 2016.
  • 2015.
  • 2014.
  • 2013.
  • 2012.

2020.

  • Sep.18.2020 Corporate
    Announcement on posting of Corporate Report 2020
  • Jun.19.2020 Corporate
    Voting Results (Extraordinary Report) of the 72nd Ordinary General Shareholders' Meeting
  • Jun.18.2020 Corporate
    Notice to Resolutions Passed at The 72nd Ordinary General Shareholders' Meeting
  • May.21.2020 Corporate
    Notice to Convene the 72nd Ordinary General Shareholders' Meeting
  • About

    About

    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies / Guidelines
  • R&D

    R&D

    • Our Mission in R&D / Drug Discovery Approach
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Organization
    • Development Pipeline
  • Global Business

    Global Business

  • Sustainability

    Sustainability

    • Top message
    • ONO's Approach to CSR
    • Governance
    • Society
    • Environment
    • Social Contribution Activities
    • Policies
    • GRI Content Index
    • CSR Report
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • Privacy Policy
  • Terms of Use
  • Site Map

COPYRIGHT © 2021 ONO PHARMACEUTICAL CO., LTD.
ALL RIGHTS RESERVED.

GoTo Top